Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR.
- 333 Open Clinical Trials
- 57 New Clinical Trials
- 1,351 New Patients
- 239 Principal Investigators
- 8 New Faculty Recruits
- 3 Newly Tenured Investigators
- 303 Staff Scientists/Staff Clinicians
- 480 Technical Lab Staff
- 773 Postdoctoral/Clinical Fellows
- 401 Postbaccalaureate/Predoctoral Students
- >1,100 Articles in Peer-Reviewed Journals
- 52 Technology Facilities and Platforms
- >50 COVID-19 Projects
- >140 COVID-19 Publications
Technology Transfer Activities
- 63 New Employee Invention Reports
- 52 Issued U.S. Patents
- 21 New Cooperative Research and Development Agreements (CRADAs)
- 9 New Clinical CRADAs
- 171 Active CRADAs
- 84 Clinical CRADAs
- 6 Umbrella CRADAs
- 24 New Clinical Trial Agreements (CTAs)
- 105 Active CTAs
- 102 New Licenses for CCR Technologies
- 655 Active Licenses
- 4 FDA Approvals
- 1 FDA Orphan Drug Designation
The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices, software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.
For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).